Photo from wikipedia
We report the first case of an investigational maglev extracorporeal ventricular assist device (extra‐VAD) use in China for a patient with cardiogenic shock post‐coronary artery bypass surgery. There were no… Click to show full abstract
We report the first case of an investigational maglev extracorporeal ventricular assist device (extra‐VAD) use in China for a patient with cardiogenic shock post‐coronary artery bypass surgery. There were no extra‐VAD devices available for clinical use in China. The patient was successfully supported for 9 days and recovered to hospital discharge. Throughout the support, the patient's haemodynamic and haematologic parameters demonstrated good patient recovery and no device‐related complications were observed. Our results encourage extra‐VAD use in short‐term to mid‐term bridging the cardiogenic shock patients in China and potentially other developing countries for both clinical and health economic benefits.
Journal Title: ESC Heart Failure
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!